Insecticides India Limited (IIL), an agrochemicals manufacturing company, is negotiating with multinational companies (MNCs) to acquire their brand rights for India, according to managing director Rajesh Aggarwal.
“Many MNCs are losing interest in generic products because of low margins. We see an opportunity in that segment. It is difficult to comment at this juncture but it (brand acquisitions) can click anytime,” he told Business Standard.
Aggarwal said the company was looking at brand acquisitions across the board, including fungicides, weedicides, insecticides and herbicides. “We are open to all areas and can invest in any brand. The size of the brand doesn’t matter. We are able to recover the money from a brand in two-three years. What we look at is getting a better foothold in the farmer’s household,” he said.
Apart from the company’s inorganic growth plans, Aggarwal said, the company was working on a collaboration for one brand (a patented fungicide product), which was expected for an announcement by May this year.
The zero-debt company currently has 95 products in its basket. As part of Phase I, it would launch seven more molecules -- Metro, Shark, Rambo, Super Star, Victor Gold in the insecticides category and a fungicide called Dynamite Plus – this financial year.
On the Monocil brand, which IIL acquired from Mumbai-based Nocil Limited yesterday, Aggarwal said the company was planning to commence manufacturing of the monocrotophos technical (Monocil) at its Dahej facility in Gujarat from this June.
“Monocil is a big brand for us. If you look at the monocrotophos market, it is at about 10 million litres annually. We are targeting 1 million litres, to begin with. And, I believe that it can take up to 20 per cent of the market share in the next two to three years,” he said.
Stating that the Monocil brand would contribute somewhere between Rs 35 crore and Rs 40 crore to the company’s topline and 20 per cent of that to the bottom line in the next financial year, Aggarwal said the company was targeting to complete sales of Rs 550 crore this financial year and touch Rs 720 crore in the next fiscal.
“We are strong in North and South India with both the regions contributing over 30 per cent and a little less than 30 per cent respectively to our revenues. We are eyeing these two regions in a big way,” he added.
Insecticides (India) Limited’s scrip ended the trade at Rs 299.85 on the BSE on Tuesday, down 6.86 per cent over the previous close of Rs 321.95.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
